TherapeuticsMD Inc (TXMD) financials · rev $3.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
TherapeuticsMD Inc (TXMD) rev $3.0M.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $3.02M | $1.76M | |
| Operating Income | −$4.39M | −$4.76M | |
| Net Income | −$569.00K | −$2.18M | |
| EPS (Diluted) | −$0.05 | −$0.19 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $37.66M | $38.82M | |
| Current Assets | $14.45M | $12.26M | |
| Cash & Equivalents | — | $5.06M | |
| Total Liabilities | $10.78M | $11.45M | |
| Current Liabilities | $4.79M | $5.17M | |
| Shareholders' Equity | $26.88M | $27.37M | |
| Retained Earnings | −$952.39M | −$951.82M |
| Line | FY2023 | FY2021 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | — | −$142.69M | |
| CapEx | — | $34.00K | |
| Investing Cash Flow | — | −$2.22M | |
| Financing Cash Flow | $3.15M | $129.55M | |
| Free Cash Flow | — | −$142.73M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is TXMD P/E and revenue?
TherapeuticsMD Inc (TXMD) rev $3.0M.
What is TXMD revenue?
TherapeuticsMD Inc last cached revenue is $3.02M (FY2025).
Is TXMD profitable?
TherapeuticsMD Inc last cached net income is -$569.0K (FY2025).
What are TXMD total assets?
TherapeuticsMD Inc last cached total assets are $37.7M (FY2025).
What is TXMD free cash flow?
No cached cash-flow row for TXMD yet.
Not investment advice. Figures as reported in company filings, not a live feed.